Pharmacon Pharmaceuticals

28/12/2025

A milestone moment for Monuril® — and for the future of uro-gynecological anti-infective management.

On 25/12/2025, at Dusit Thani, Pharmacon had the honor of hosting a high-level Advisory Board Meeting, bringing together a distinguished panel of Egypt’s leading professors in Urology and Gynaecology to align on a shared, evidence-based clinical vision.

This elite scientific forum resulted in a consensus-driven clinical algorithm that clearly defined:

▪️ Evidence-based clinical indications for Monuril®
▪️ Its differentiated positioning within today’s crowded anti-infective landscape
▪️ Its role in addressing a critical therapeutic gap across both urology and gynaecology

The discussion reaffirmed that Monuril® is not merely another option, but a strategic, guideline-aligned solution that responds to real-world practice challenges, antimicrobial resistance, and evolving patient needs.

We were deeply honored by the valuable insights and participation of a distinguished group of experts, including professors and leaders from the fields of urology and gynaecology, whose contributions enriched the scientific depth and
clinical relevance of this meeting.

Prof. Sherif Mourad, Professor of Urology & President of EUA
Prof. Ihab Serag, Professor of Gynaecology & Head of Uro-Gyna Dept., Ain Shams University
Prof. Amr Nowir, Professor of Urology
Prof. Galal Elshorbagy, Professor of Urology
Prof. Abdel Latif El Kholy, Professor of Gynaecology
Prof. Hassan Gaafar, Professor of Gynaecology
Prof. Omar Shaaban, Professor of Gynaecology
Prof. Ayman Abo Elnour, Professor of Gynaecology
Prof. Osama Azmy, Professor of Gynaecology
Prof. Hazim Samour, Professor of Gynaecology
Prof. Hassan Morsi, Professor of Gynaecology
Prof. Khaled Swidan, Professor of Gynaecology
Prof. Hany Faiomy, Professor of Urology
Prof. Mostafa Abdelmohsen, Professor of Urology

This Advisory Board highlighted a clear reality:
Only Pharmacon can introduce Monuril® with the scientific rigor, clinical confidence, and quality excellence required to lead this category.

Proud of what was achieved.
Inspired by what lies ahead.

This is how consensus becomes practice.

22/12/2025

👌🏼💯

رئتك محتاجة رعاية .. مش تجاهل
بين رئة متأثرة بالدخان و الإهمال, و رئة نظيفة و سليمة بفضل العناية و الاختيار الصح .. الفرق واضح. فلوموسيل بيساعدك تحافظ على صحة رئتيك توقفك عن التدخين يعزز دور فلوموسيل في اذابة الإفرازات المخاطية المتراكمة في جهازك التنفسي

#راحة في كل نفس بعد علاج البلغم
#فلوموسيل أستيل سيستين 600 مج
#أقراص فوارة بطعم الليمون
#مستورد من سويسرا بجودة و فعالية عالية

لمعرفة المزيد عن المستحضر:
https://heyzine.com/flip-book/c814cb9966.html

22/12/2025

💯👌🏼

أثر البلغم مش بسيط!
البلغم ممكن يأثر على نومك، شغلك، ومزاجك
فلوموسيل حل هيريّحك بجد

#راحة في كل نفس بعد علاج البلغم
#فلوموسيل أستيل سيستين 600 مج
#أقراص فوارة بطعم الليمون
#مستورد من سويسرا بجودة و فعالية عالية

لمعرفة المزيد عن المستحضر:
https://heyzine.com/flip-book/c814cb9966.html

09/12/2025

We were honored to participate in ..
Egyptian Urologist Association 2025 in Cairo
through our Monuril Booth and scientific symposium.

A valuable opportunity to engage with distinguished urologists and support evidence-based UTI management.

06/12/2025

Spididol 600
Available in distributors and most pharmacies and all chains like saif and Elezaby pharmacy

01/12/2025

Pharmacon Pharmaceuticals is proud to participate in the 6th Annual International Gynecology Conference (AAGC), showcasing our commitment to advancing women’s health through science and innovation.

This year, Pharmacon supported an interactive and high-value scientific symposium delivered by Prof. Ayman Abo Elnour, titled:
“Urinary Antimicrobial for OBGYN: An Interactive Session.”

The session was proudly sponsored by Monuril® (Fosfomycin Trometamol) — the first-line, single-shot therapy for lower urinary tract infections, and the only clinically proven safe option during pregnancy.

Our participation reflects Pharmacon’s ongoing mission to empower healthcare professionals with evidence-based solutions and contribute to meaningful scientific exchange across the gynecology community.

Proud to continue driving better outcomes for women’s health.

30/11/2025

Day 4 – 77th EOA Annual Meeting

We were honored to participate in the fourth day of the 77th Annual Meeting of the Egyptian Orthopaedic Association, which featured an outstanding and highly informative lecture by Prof. Gamal Hosny titled:
“Osteoarthritis Management: New Options.”

The session provided an in-depth overview of current evidence, evolving management pathways, and innovative therapeutic options that hold significant potential for improving outcomes in osteoarthritis care.

Our presence at this important scientific platform reflects Pharmacon’s ongoing commitment to supporting the orthopaedic community through:

Advancing scientific knowledge

Encouraging continuous medical education

Providing evidence-based, high-quality healthcare solutions

We extend our appreciation to all the experts, partners, and healthcare professionals who engaged with us at our booth. Your valuable discussions and insights strengthen our mission to contribute meaningfully to the advancement of healthcare in Egypt.

25/11/2025

We are proud to have participated in the 77th Annual Meeting of the Egyptian Orthopaedic Association (EOA), where we connected with leading experts, surgeons, and innovators in the field of orthopaedics.

At Pharmacon, our commitment goes beyond providing high-quality pharmaceutical solutions. We are dedicated to supporting Egypt’s healthcare community through continuous scientific education and empowering healthcare professionals with up-to-date medical knowledge.
Through our specialized scientific activities and engagement in key medical events like the EOA Congress, we strive to contribute to better patient outcomes across Egypt.

Thank you to everyone who visited our booth — we look forward to continuing our mission of advancing healthcare and serving the Egyptian patient with excellence.

18/09/2025

Job Title: Senior Product Specialist – Orthopedic Intra-articular hyaluronic acid injection
Department: Sales
Job Purpose
To achieve sales targets, develop strong customer relationships, and increase market share of the company’s orthopedic Intra-articular hyaluronic acid injection portfolio through effective territory management, scientific knowledge, and promotional activities.
Key Responsibilities
Achieve and exceed monthly, quarterly, and annual sales targets.
Identify and develop new business opportunities within the orthopedic KOL.
Maintain and expand customer base by building strong relationships with healthcare professionals such as orthopedic
Deliver high-quality product presentations
Organize and participate in medical events, workshops, and product demonstrations.
Provide accurate, up-to-date product and therapeutic area knowledge to customers.
Plan and implement effective field visits to maximize coverage and frequency.
Monitor competitor activities, pricing, and market trends.
Maintain accurate records of customer profiles, visits, and follow-up actions in CRM tools.
Coordinate with the marketing team for promotional materials and campaigns.
Provide feedback from the field to support market intelligence and product strategies.
Submit timely sales reports, activity reports, and market analysis.
Ensure all activities comply with company policies, industry regulations, and ethical standards.
Qualifications & Skills
Education: Bachelor’s degree in Pharmacy, Medicine, Veterinary Medicine, or Science (Biology/Chemistry).
Experience:
Minimum 3–5 years in pharmaceutical sales Orthopedic is must.
Proven track record in orthopedic Intra-articular hyaluronic acid injections.
Skills:
Strong communication, negotiation, and presentation skills.
Deep understanding of orthopedic therapeutic areas.
Ability to analyze data and generate actionable insights.
Performance Indicators (KPIs)
Achievement of sales targets.
Growth of market share in the assigned territory.
Frequency and quality of customer interactions.
Customer satisfaction and retention rate.

11/09/2025